<DOC>
	<DOCNO>NCT02603315</DOCNO>
	<brief_summary>The purpose study To assess correlation predictive factor vascularity ( CD74 ) malignant pleural mesothelioma treatment result ( response rate , overall survival ) .</brief_summary>
	<brief_title>Vascularity Impact Treatment Outcome Malignant Pleural Mesothelioma ( VITMPM )</brief_title>
	<detailed_description>This randomize control retrospective study Examination paraffin block patient select include study assessment select vascularity marker malignant pleural mesothelioma type . The CD74 ( LN2 ) antibody intend qualified laboratory qualitatively identify light microscopy presence associate antigens section formalin-fixed paraffin-embedded tissue section use Immunohistochemistry test method .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Histopathological confirmation malignant pleural mesothelioma . Full clinical data . Availability follow : Personal communication attempt order collect miss information . 3The file patient review analyze following : Operative data do . Pathological review immunohistochemistry . Laboratory investigation : ( routine investigation : complete blood picture , liver renal function test ) Radiological investigation : ( CXR CTchest , Abdominal pelvic U\S MRI ) . Treatment protocols apply : Radiotherapy Chemotherapy . Response survival treatment . case receive chemotherapy , available evaluation treatment</criteria>
	<gender>All</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>